Uri Geiger
CIK 1467361 · last filed 2026-06-22
Uri Geiger is a corporate insider who has filed 17 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider was granted $12.3K of NPCE on Jun 22, 2026. Across all open-market trades the lifetime net is +$724.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $68.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$68.15M
4
17
$724.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NPCE | Director | 4,451,485 | $15.31 | $68.15M | $0 | 10 | 2026-06-22 |
| STRATA Skin Sciences, Inc. (SSKN) Delisted | Director | 1,441,835 | $0.15 | $216.1K | $724.0K | 3 | 2024-07-17 |
| CGNT | Director | 0 | $8.92 | $0 | $0 | 1 | 2018-04-23 |
| EndoChoice Holdings, Inc. (GI) Delisted | Director | 2,284,989 | — | — | $0 | 2 | 2015-11-19 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | NPCE | Grant (A) | +789 | $12.3K | EDGAR |
| 2026-06-05 | NPCE | Grant (A) | +2,890 | $0 | EDGAR |
| 2026-03-24 | NPCE | Grant (A) | +913 | $11.9K | EDGAR |
| 2025-12-23 | NPCE | Grant (A) | +715 | $11.9K | EDGAR |
| 2025-09-22 | NPCE | Grant (A) | +1,194 | $11.9K | EDGAR |
| 2025-06-24 | NPCE | Grant (A) | +12,036 | $105.4K | EDGAR |
| 2025-06-09 | NPCE | Grant (A) | — | $0 | EDGAR |
| 2024-07-17 | STRATA Skin Sciences, Inc. (SSKN) Delisted | Buy (P) | +230,573 | $724.0K | EDGAR |
| 2024-06-11 | NPCE | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | NPCE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.